Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Universal Technical Institute Inc (NYSE: UTI) closed at $31.86 down -1.36% from its previous closing price of $32.3. In other words, the price has decreased by -$1.36 from its previous closing price. On the day, 0.68 million shares were traded. UTI stock price reached its highest trading level at $32.3 during the session, while it also had its lowest trading level at $31.46.
Ratios:
For a deeper understanding of Universal Technical Institute Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.45. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.79.
On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22.
On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 27 ’25 when Coliseum Capital Management, L sold 500,000 shares for $35.00 per share. The transaction valued at 17,500,000 led to the insider holds 2,716,267 shares of the business.
Hitchcock Todd A sold 27,500 shares of UTI for $917,471 on May 15 ’25. The EVP/COO now owns 80,521 shares after completing the transaction at $33.36 per share. On May 13 ’25, another insider, Brochick George W., who serves as the Director of the company, sold 6,000 shares for $31.84 each. As a result, the insider received 191,040 and left with 32,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 1733381504 and an Enterprise Value of 1964554624. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.72, and their Forward P/E ratio for the next fiscal year is 29.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.21 while its Price-to-Book (P/B) ratio in mrq is 5.90. Its current Enterprise Value per Revenue stands at 2.51 whereas that against EBITDA is 17.986.
Stock Price History:
The Beta on a monthly basis for UTI is 1.59, which has changed by 1.0062971 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $36.32, while it has fallen to a 52-week low of $15.14. The 50-Day Moving Average of the stock is -3.23%, while the 200-Day Moving Average is calculated to be 22.81%.
Shares Statistics:
For the past three months, UTI has traded an average of 824.65K shares per day and 796430 over the past ten days. A total of 54.41M shares are outstanding, with a floating share count of 50.26M. Insiders hold about 7.62% of the company’s shares, while institutions hold 87.19% stake in the company. Shares short for UTI as of 1749772800 were 2329777 with a Short Ratio of 2.83, compared to 1747267200 on 1596255. Therefore, it implies a Short% of Shares Outstanding of 2329777 and a Short% of Float of 5.050000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 3.72.
